Schuhmacher, A., Hinder, M., von Stegmann Und Stein, A., Hartl, D. & Gassmann, O. Analysis of pharma R&D productivity — a new perspective needed. Drug Discov. Today 28, 103726 (2023).

Article  PubMed  Google Scholar 

Facchinetti, F. et al. Facts and new hopes on selective FGFR inhibitors in solid tumors. Clin. Cancer Res. 26, 764–774 (2020).

Article  CAS  PubMed  Google Scholar 

Murtaza, M. et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat. Commun. 6, 8760 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Ding, Z., Wang, N., Ji, N. & Chen, Z.-S. Proteomics technologies for cancer liquid biopsies. Mol. Cancer 21, 53 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Uhlén, M. et al. The human secretome. Sci. Signal. 12, eaaz0274 (2019).

Article  PubMed  Google Scholar 

Wang, W., Zhen, S., Ping, Y., Wang, L. & Zhang, Y. Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring. Front. Oncol. 14, 1331215 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Álvez, M. B. et al. Next generation pan-cancer blood proteome profiling using proximity extension assay. Nat. Commun. 14, 4308 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Lu, C., Bonini, A., Viel, J. H. & Maglia, G. Toward single-molecule protein sequencing using nanopores. Nat. Biotechnol. 43, 312–322 (2025).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mouliere, F. et al. Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. EMBO Mol. Med. 10, e9323 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Rapado-González, Ó et al. Salivary biomarkers for cancer diagnosis: a meta-analysis. Ann. Med. 52, 131–144 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Wolf, J. et al. Liquid biopsy proteomics in ophthalmology. J. Proteome Res. 23, 511–522 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arrichiello, G., Nacca, V., Paragliola, F. & Giunta, E. F. Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives. Explor. Target. Antitumor Ther. 3, 362–374 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Berry, J. L. et al. Aqueous humor liquid biopsy as a companion diagnostic for retinoblastoma: implications for diagnosis, prognosis, and therapeutic options: five years of progress. Am. J. Ophthalmol. 263, 188–205 (2024).

Article  CAS  PubMed  Google Scholar 

Saura, C. et al. Early-stage breast cancer detection in breast milk. Cancer Discov. 13, 2180–2191 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Chan, C. & Chan, K. K. P. Pleural fluid biomarkers: a narrative review. J. Thorac. Dis. 16, 4764–4771 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Wu, H. et al. Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancers. BMC Cancer 22, 1020 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bronkhorst, A. J., Ungerer, V. & Holdenrieder, S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol. Detect. Quantif. 17, 100087 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jahr, S. et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61, 1659–1665 (2001).

CAS  PubMed  Google Scholar 

Mair, R. et al. Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models. Cancer Res. 79, 220–230 (2019).

Article  CAS  PubMed  Google Scholar 

van der Meer, A. J. et al. Systemic inflammation induces release of cell-free DNA from hematopoietic and parenchymal cells in mice and humans. Blood Adv. 3, 724–728 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Teo, Y. V. et al. Cell-free DNA as a biomarker of aging. Aging Cell 18, e12890 (2019).

Article  PubMed  Google Scholar 

Moss, J. et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat. Commun. 9, 5068 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Neuberger, E. W. I. et al. Physical activity specifically evokes release of cell-free DNA from granulocytes thereby affecting liquid biopsy. Clin. Epigenet. 14, 29 (2022).

Article  CAS  Google Scholar 

Cao, J. et al. DNA-sensing inflammasomes cause recurrent atherosclerotic stroke. Nature 633, 433–441 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

van der Pol, Y. & Mouliere, F. Toward the early detection of cancer by decoding the epigenetic and environmental fingerprints of cell-free DNA. Cancer Cell 36, 350–368 (2019).

Article  PubMed  Google Scholar 

Cheng, A. P. et al. A cell-free DNA metagenomic sequencing assay that integrates the host injury response to infection. Proc. Natl Acad. Sci. USA 116, 18738–18744 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan, R. W. Y. et al. Plasma DNA aberrations in systemic lupus erythematosus revealed by genomic and methylomic sequencing. Proc. Natl Acad. Sci. USA 111, E5302–E5311 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tabrizi, S. et al. Modulating cell-free DNA biology as the next frontier in liquid biopsies. Trends Cell Biol. 35, 459–469 (2025).

Article  CAS  PubMed  Google Scholar 

Carter, L. et al. Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer. Nat. Med. 23, 114–119 (2017).

Article  CAS  PubMed  Google Scholar 

Chemi, F. et al. Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse. Nat. Med. 25, 1534–1539 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valpione, S. et al. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients. Eur. J. Cancer 88, 1–9 (2018).

Article  CAS  PubMed  Google Scholar